Bd marks 1,000th bd rhapsody system, driving scientific breakthroughs via single-cell multiomics

Franklin lakes, n.j. , sept. 17, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, announced the placement of the 1,000th bd rhapsody™ system, a flagship instrument for single-cell multiomics analysis, at addenbrooke's hospital of the university of cambridge, united kingdom.
BDX Ratings Summary
BDX Quant Ranking